More on ATTO
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $22.53 |
|
|||
| Open | $22.43 | ||||
| 52 Wk High | $11.52 | ||||
| 52 Wk Low | $6.77 | ||||
| Day High | $24.22 | ||||
| Day Low | $22.00 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 175,770 | ||||
- Attovia Therapeutics to Participate in Upcoming Investor Conferences
- Attovia Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
- Wall Street analysts bullish on Attovia as itch drug data fuel biotech optimism
- Leerink Starts Attovia Therapeutics (ATTO) at Outperform
- LifeSci Capital Starts Attovia Therapeutics (ATTO) at Outperform
- Citi Starts Attovia Therapeutics (ATTO) at Buy
- RBC Capital Starts Attovia Therapeutics (ATTO) at Outperform
- Morgan Stanley Starts Attovia Therapeutics (ATTO) at Overweight
- Form 4/A Attovia Therapeutics, For: Aug 05 Filed by: WALSH COLIN
- Form 4/A Attovia Therapeutics, For: Aug 05 Filed by: GOLDMAN SACHS & CO. LLC
Entities mentioned with ATTO
- Bankruptcy | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- IPO | View Related Stories »
- Morgan Stanley | View Related Stories »
- Credit Suisse | View Related Stories »
- 13D | View Related Stories »
- Bain Capital | View Related Stories »
- Show More...
